About Alveo Technologies
Alveo Technologies is a company based in Alameda (United States) founded in 2014 by Mike Aicher and Lawrence M Blatt.. Alveo Technologies has raised $63.61 million across 3 funding rounds from investors including Gates Foundation and Maxim Group. Alveo Technologies offers products and services including Alveo Sense™ Poultry Avian Influenza Test and Alveo Platform. Alveo Technologies operates in a competitive market with competitors including NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Bioskryb, among others.
- Headquarter Alameda, United States
- Founders Mike Aicher, Lawrence M Blatt
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alveo S.R.O.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$63.61 M (USD)
in 3 rounds
-
Latest Funding Round
$16 M (USD), Series A
Mar 29, 2021
-
Investors
Gates Foundation
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alveo Technologies
Alveo Technologies offers a comprehensive portfolio of products and services, including Alveo Sense™ Poultry Avian Influenza Test and Alveo Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid molecular tool for detecting avian influenza in poultry samples.
Handheld analyzer for on-site pathogen testing in various sectors.
Unlock access to complete
Unlock access to complete
Funding Insights of Alveo Technologies
Alveo Technologies has successfully raised a total of $63.61M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $16 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $16.0M
-
First Round
First Round
(05 Jan 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series A - Alveo Technologies | Valuation |
investors |
|
| Nov, 2020 | Amount | Grant - Alveo Technologies | Valuation |
investors |
|
| Jan, 2018 | Amount | Series A - Alveo Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alveo Technologies
Alveo Technologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Gates Foundation and Maxim Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Financial advisory services are provided across multiple sectors.
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alveo Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alveo Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alveo Technologies Comparisons
Competitors of Alveo Technologies
Alveo Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Bioskryb, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| domain | founded_year | HQ Location |
Provider of point of care molecular diagnostics solutions
|
|
| domain | founded_year | HQ Location |
Genome amplification systems for DNA sequencing are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alveo Technologies
Frequently Asked Questions about Alveo Technologies
When was Alveo Technologies founded?
Alveo Technologies was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Alveo Technologies located?
Alveo Technologies is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Is Alveo Technologies a funded company?
Alveo Technologies is a funded company, having raised a total of $63.61M across 3 funding rounds to date. The company's 1st funding round was a Series A of $47.61M, raised on Jan 05, 2018.
What does Alveo Technologies do?
Alveo Technologies is an early-stage biotech company developing point of care molecular diagnostic devices. Alveos technology incorporates cloud-based analytics with rapid, point of care molecular testing to create an integrated, connected solution for infectious disease diagnostics.
Who are the top competitors of Alveo Technologies?
Alveo Technologies's top competitors include GenMark Diagnostics, NeuMoDx and Bioskryb.
What products or services does Alveo Technologies offer?
Alveo Technologies offers Alveo Sense™ Poultry Avian Influenza Test and Alveo Platform.
Who are Alveo Technologies's investors?
Alveo Technologies has 2 investors. Key investors include Gates Foundation, and Maxim Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.